APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT04942067 · UNKNOWN
Trial details
- NCT number
- NCT04942067
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-23
- Primary completion
- 2024-09-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.